I. Banu

546 total citations
28 papers, 331 citations indexed

About

I. Banu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, I. Banu has authored 28 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in I. Banu's work include Diabetes Treatment and Management (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cardiovascular Function and Risk Factors (6 papers). I. Banu is often cited by papers focused on Diabetes Treatment and Management (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cardiovascular Function and Risk Factors (6 papers). I. Banu collaborates with scholars based in France, United States and Luxembourg. I. Banu's co-authors include Emmanuel Cosson, P. Valensi, Minh Tuan Nguyen, Paul Valensi, I. Pharisien, Lionel Carbillon, M.T. Nguyen, Françoise Gary, Tuan M. Nguyen and Soumiya Chiheb and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetologia.

In The Last Decade

I. Banu

25 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Banu France 10 158 110 76 61 37 28 331
Arend W. van Deutekom Netherlands 12 76 0.5× 62 0.6× 63 0.8× 58 1.0× 120 3.2× 20 349
Domenico Labriola Italy 8 43 0.3× 89 0.8× 58 0.8× 55 0.9× 33 0.9× 17 309
Jeffrey Sanfield United States 6 79 0.5× 97 0.9× 77 1.0× 49 0.8× 44 1.2× 7 275
Daniel Faucher Canada 11 32 0.2× 61 0.6× 122 1.6× 32 0.5× 142 3.8× 21 366
Sophie Buller United Kingdom 6 24 0.2× 58 0.5× 25 0.3× 13 0.2× 85 2.3× 8 181
Dominique Ballaux Belgium 9 122 0.8× 40 0.4× 78 1.0× 22 0.4× 20 0.5× 17 307
Andrew D. Morris United Kingdom 8 80 0.5× 10 0.1× 22 0.3× 120 2.0× 29 0.8× 9 266
Elham Ehrampoush Iran 11 55 0.3× 35 0.3× 32 0.4× 26 0.4× 21 0.6× 22 320
U. Gudat Germany 7 190 1.2× 8 0.1× 86 1.1× 74 1.2× 16 0.4× 12 304
Kylie McLachlan Australia 6 81 0.5× 229 2.1× 63 0.8× 14 0.2× 89 2.4× 8 326

Countries citing papers authored by I. Banu

Since Specialization
Citations

This map shows the geographic impact of I. Banu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Banu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Banu more than expected).

Fields of papers citing papers by I. Banu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Banu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Banu. The network helps show where I. Banu may publish in the future.

Co-authorship network of co-authors of I. Banu

This figure shows the co-authorship network connecting the top 25 collaborators of I. Banu. A scholar is included among the top collaborators of I. Banu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Banu. I. Banu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picard, Sylvie, Jean‐Pierre Riveline, Jean‐Baptiste Julla, et al.. (2025). Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study. Diabetes & Metabolism. 51(4). 101647–101647.
2.
Choudhary, Pratik, Emmanuel Cosson, I. Banu, et al.. (2025). Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes—the critical role of hypoglycaemia awareness: results from the SFDT1 study. Diabetologia. 68(12). 2719–2731. 1 indexed citations
3.
Banu, I., et al.. (2020). A Case of Late-Detected Pheochromocytoma in a Young Patient With Resistant Hypertension and Hypertrophic Cardiomyopathy. American Journal of Hypertension. 34(1). 117–120. 3 indexed citations
4.
Banu, I., et al.. (2019). Une iatrogénie méconnue des antithyroïdiens de synthèse : la pancréatite aiguë. La Presse Médicale. 48(11). 1334–1336. 2 indexed citations
5.
Cosson, Emmanuel, Éric Vicaut, Françoise Gary, et al.. (2018). Early screening for gestational diabetes mellitus is not associated with improved pregnancy outcomes: an observational study including 9795 women. Diabetes & Metabolism. 45(5). 465–472. 29 indexed citations
6.
Cosson, Emmanuel, Françoise Gary, I. Pharisien, et al.. (2017). Poor Reliability and Poor Adherence to Self-Monitoring of Blood Glucose Are Common in Women With Gestational Diabetes Mellitus and May Be Associated With Poor Pregnancy Outcomes. Diabetes Care. 40(9). 1181–1186. 50 indexed citations
7.
Cosson, Emmanuel, Abou Diallo, I. Banu, et al.. (2016). Fetal gender is not associated with either gestational diabetes mellitus or placental weight: A cohort study. Diabetes & Metabolism. 42(4). 276–279. 8 indexed citations
8.
9.
Banu, I., et al.. (2015). Relation entre pression artérielle, fréquence cardiaque et dysfonction autonome cardiaque chez les obèses non diabétiques. Annales de Cardiologie et d Angéiologie. 64(3). 139–144. 4 indexed citations
10.
Cosson, Emmanuel, et al.. (2015). P015 Score calcique coronaire élevé : un outil décisionnel pour le dépistage de l’ischémie myocardique silencieuse du diabétique ?. Diabetes & Metabolism. 41. A36–A36. 1 indexed citations
11.
12.
Cosson, Emmanuel, Amélie Benbara, I. Pharisien, et al.. (2014). The Diagnostic and Prognostic Performance of a Selective Screening Strategy for Gestational Diabetes Mellitus According to Ethnicity in Europe. The Journal of Clinical Endocrinology & Metabolism. 99(3). 996–1005. 29 indexed citations
13.
Cosson, Emmanuel, Soumiya Chiheb, I. Banu, et al.. (2012). Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes & Metabolism. 39(2). 118–125. 7 indexed citations
14.
Cosson, Emmanuel, Soumiya Chiheb, Tuan M. Nguyen, et al.. (2012). Use of clinical scores to detect dysglycaemia in overweight or obese women. Diabetes & Metabolism. 38(3). 217–224. 6 indexed citations
15.
16.
Banu, I. & P. Valensi. (2011). Hypoglycémie et effets cardiovasculaires. Médecine des Maladies Métaboliques. 5(4). 399–405. 1 indexed citations
17.
Cosson, Emmanuel, et al.. (2011). Cardiovascular Risk Prediction Is Improved by Adding Asymptomatic Coronary Status to Routine Risk Assessment in Type 2 Diabetic Patients. Diabetes Care. 34(9). 2101–2107. 31 indexed citations
18.
19.
Cosson, Emmanuel, Tuan M. Nguyen, I. Banu, et al.. (2010). What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998–2006?. Diabetic Medicine. 28(5). 567–574. 15 indexed citations
20.
Paineau, Damien, I. Banu, P. Valensi, et al.. (2008). Comparison of field methods to estimate fat mass in children. Annals of Human Biology. 35(2). 185–197. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arend W. van Deutekom Breakdown of academic impact, for papers by Domenico Labriola Breakdown of academic impact, for papers by Jeffrey Sanfield Breakdown of academic impact, for papers by Daniel Faucher Breakdown of academic impact, for papers by Sophie Buller Breakdown of academic impact, for papers by Dominique Ballaux Breakdown of academic impact, for papers by Andrew D. Morris Breakdown of academic impact, for papers by Elham Ehrampoush Breakdown of academic impact, for papers by U. Gudat Breakdown of academic impact, for papers by Kylie McLachlan
Rankless by CCL
2026